Skip to main content
. Author manuscript; available in PMC: 2016 Apr 6.
Published in final edited form as: Neuroscience. 2003;122(4):1013–1023. doi: 10.1016/j.neuroscience.2003.08.033

Fig. 4.

Fig. 4

Time-lapse digital micrographs of striatal neurons in untreated, dynorphin A (1–17)-treated, or dynorphin A (1–17) + caspase inhibitor Z-DEVD-FMK-treated cultures. Untreated cultures showed few degenerating neurons (A–B), while exposure to dynorphin A (1–17) (10 μM) caused significant toxicity (C–D) that could be attenuated by Z-DEVD-FMK (30 μM) (E–F); non-degenerating neurons (white arrows), degenerating neurons (black arrows), scale bar = 25 μm.